Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Pharmacology & Toxicology|May 1, 1987
Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brainH Hall, M SällemarkActa Pharmacologica Et Toxicologica|January 1, 1986
Effects of remoxipride and some related new substituted salicylamides on rat brain receptorsH Hall, M Sällemark, E JerningActa Pharmacologica Et Toxicologica|May 1, 1984
Acute effects of atypical antidepressants on various receptors in the rat brainH Hall, M Sällemark, I WedelJournal of Neural Transmission|January 1, 1984
Effect of destruction of central noradrenergic and serotonergic nerve terminals by systemic neurotoxins on the long-term effects of antidepressants on beta-adrenoceptors and 5-HT2 binding sites in the rat cerebral cortexH Hall, S B Ross, M SällemarkEuropean Journal of Pharmacology|July 6, 1993
Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptorsN Mohell, M Sällemark, S Rosqvist, et al.Journal of Medicinal Chemistry|January 1, 1986
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamidesT de Paulis, Y Kumar, L Johansson, et al.The Journal of Pharmacology and Experimental Therapeutics|November 21, 2001
The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonistL Rënyi, J L Evenden, C J Fowler, et al.Pageof 1